I don’t think they’re needed,” said George Tidmarsh, head of the FDA’s Center for Drug Evaluation and Research.

On top of that, drug ads must provide “fair balance,” meaning the positives and negatives have to both be presented. In ...

If you're not over 65 or have certain risk factors, it might be hard to get one but not necessarily impossible. Here's what ...

FDA officials plan to present data they claim links the Covid vaccine to 25 deaths in children at a CDC vaccine panel meeting ...

Can these microscopic cell messengers really help regrow lost hair or undo signs of aging? Here are the facts, according to ...

New FDA rules limit COVID-19 vaccines to older adults, high-risk patients, or those with prescriptions, leaving SC pharmacies ...

The standing order enables people ages 65 and older, as well as those ages 18 to 64 with at least one high-risk condition, to get the 2026-26 COVID vaccine booster ...

North Carolina Governor Josh Stein and other state health officials announced Friday that COVID-19 vaccines would be more accessible as the virus continues to spread and federal recommendations have ...

Pharma and biotech stocks have struggled lately. Argus Research's Jasper Hellweg discusses how new treatment types and US ...

Arizona Gov. Katie Hobbs issued an executive order Sept. 11, 2025, mandating state agencies give residents "broad access" to updated COVID vaccines.

You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists like Ozempic®, Wegovy®, Mounjaro®, and Zepbound®. While Ozempic can be ...